Audhya Paul K.

CIK 00018601311 companyFRAMINGHAM, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001860131

Recent Transactions

20 trades

Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-24$13.45/sh−5,296→ 131,831 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-24$13.45/sh−5,296→ 131,831 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-24$13.45/sh−5,296→ 131,831 total
Sale
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-24$13.45/sh−5,296→ 131,831 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-22+5,000→ 137,127 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-22−5,000→ 50,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-22+5,000→ 137,127 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-22−5,000→ 50,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-22+5,000→ 137,127 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-22−5,000→ 50,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-22−5,000→ 50,000 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-22+5,000→ 137,127 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-21+6,250→ 132,127 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-21−6,250→ 81,250 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-21+6,250→ 132,127 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-21−6,250→ 81,250 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-21+6,250→ 132,127 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-21−6,250→ 81,250 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Common Stock
2025-11-21+6,250→ 132,127 total
Exercise/Conversion
KalVista Pharmaceuticals, Inc.$KALV
Restricted Stock Unit
2025-11-21−6,250→ 81,250 total

Companies

KalVista Pharmaceuticals, Inc.
CHIEF MEDICAL OFFICER
$KALV

Recent Filings

4
Audhya Paul K.
Nov 26, 2025

Address

C/O KALVISTA PHARMACEUTICALS, INC. 200 CROSSING BOULEVARD

FRAMINGHAM, MA, 01702

View on SEC.gov